CD19 CAR-T Cell Therapy at the LMU Munich from 2019 to 2021: Increasing Therapy Safety over the Years

被引：0
|
作者：
Bucklein, V [1 ,2 ,3 ]
Blumenberg, V [1 ,2 ,4 ]
Frolich, L. [1 ,4 ]
Ackermann, J. [1 ]
Schmidt, C. [1 ]
Hildebrand, F. [1 ,2 ]
Rejeski, K. [1 ,2 ,4 ]
Winkelmann, M. [5 ]
Schoberl, F. [6 ]
Kunz, W.
Von Baumgarten, L. [1 ,3 ,7 ]
Humpe, A. [8 ]
Von Bergwelt, M. [3 ,4 ]
Subklewe, M. [1 ,2 ,3 ,4 ]
机构：
[1] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Med 3, Munich, Germany
[2] LMU Gene Ctr, Lab Translat Canc Immunol, Munich, Germany
[3] Bavarian Canc Res Ctr BZKF, Munich, Germany
[4] German Canc Consortium DKTK, German Canc Res Ctr DKFZ, Heidelberg, Germany
[5] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Radiol, Munich, Germany
[6] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Neurol, Munich, Germany
[7] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Neurosurg, Munich, Germany
[8] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Transfus Med, Munich, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2022年 / 45卷 / SUPPL 2期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P388
引用
收藏
页码：125 / 125
页数：1
相关论文
共 50 条
  • [21] Humanized CD19 CAR-T cells in relapsed/refractory B-ALL patients who relapsed after or failed murine CD19 CAR-T therapy
    Lihong An
    Yuehui Lin
    Biping Deng
    Zhichao Yin
    Defeng Zhao
    Zhuojun Ling
    Tong Wu
    Yongqiang Zhao
    Alex H. Chang
    Chunrong Tong
    Shuangyou Liu
    BMC Cancer, 22
  • [22] Two years later: CD19 CAR-T going the distance
    Darnell, Eli P.
    Frigault, Matthew J.
    BLOOD, 2024, 143 (05) : 379 - 380
  • [23] Severe hematotoxicity after CD19 CAR-T therapy is associated with suppressive immune dysregulation and limited CAR-T expansion
    Rejeski, Kai
    Perez, Ariel
    Iacoboni, Gloria
    Blumenberg, Viktoria
    Buecklein, Veit L.
    Voelkl, Simon
    Penack, Olaf
    Albanyan, Omar
    Stock, Sophia
    Mueller, Fabian
    Karschnia, Philipp
    Petrera, Agnese
    Reid, Kayla
    Faramand, Rawan
    Davila, Marco L.
    Modi, Karnav
    Dean, Erin A.
    Bachmeier, Christina
    von Bergwelt-Baildon, Michael
    Locke, Frederick L.
    Bethge, Wolfgang
    Bullinger, Lars
    Mackensen, Andreas
    Barba, Pere
    Jain, Michael D.
    Subklewe, Marion
    SCIENCE ADVANCES, 2023, 9 (38)
  • [24] Infectious complications among CD19 CAR-T cell therapy recipients: A single-center experience
    Walker, Bryan
    Zimmer, Andrea J.
    Stohs, Erica J.
    Lunning, Matthew
    Lyden, Elizabeth
    Abbas, Anum
    TRANSPLANT INFECTIOUS DISEASE, 2023, 25
  • [25] Infectious complications among CD19 CAR-T cell therapy recipients: A single-center experience
    Walker, Bryan
    Zimmer, Andrea J.
    Stohs, Erica J.
    Lunning, Matthew
    Lyden, Elizabeth
    Abbas, Anum
    TRANSPLANT INFECTIOUS DISEASE, 2023, 25
  • [26] Reduced ABO blood group antibody titers in patients after CD19 CAR-T cell therapy
    Li, Qiang
    Yang, Zhihuan
    Fang, Kuo
    Wei, Shuning
    Sun, Jiali
    Liu, Wei
    Chen, Xiaojuan
    Huang, Wenyang
    Zhang, Guangji
    Shi, Yin
    Liu, Yuntao
    Gong, Xiaoyuan
    Liu, Fang
    Zhou, Xueli
    Wang, Jianxiang
    Wang, Ying
    BLOOD SCIENCE, 2023, 5 (01): : 62 - 65
  • [27] CD19 CAR T cell therapy effective for systemic lupus erythematosus
    Gelfand, J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (01) : 4 - 4
  • [28] Bone Marrow Fibrosis Is Associated with Non-Response to CD19 CAR-T Therapy
    Anil, Joshua
    Lytle, Andrew
    Alnemri, Ahab
    Lockhart, Brian
    Pillai, Vinodh
    BLOOD, 2022, 140 : 9194 - 9195
  • [29] Paving the road ahead for CD19 CAR T-cell therapy
    Nellan, Anandani
    Lee, Daniel W.
    CURRENT OPINION IN HEMATOLOGY, 2015, 22 (06) : 516 - 520
  • [30] Safety and feasibility of stem cell boost as a salvage therapy for severe hematotoxicity after CD19 CAR T-cell therapy
    Rejeski, Kai
    Burchert, Andreas
    Iacoboni, Gloria
    Sesques, Pierre
    Fransecky, Lars
    Buecklein, Veit
    Trenker, Corinna
    Hernani, Rafael
    Naumann, Ralph
    Schaefer, Jonas
    Blumenberg, Viktoria
    Schmidt, Christian
    Sohlbach, Kristina
    von Bergwelt-Baildon, Michael
    Bachy, Emmanuel
    Barba, Pere
    Subklewe, Marion
    BLOOD ADVANCES, 2022, 6 (16) : 4719 - 4725
12345